{
  "id": 567962,
  "title": "Ex-Legend chief Ying Huang becomes CEO of K2, eyes $250M Series A",
  "url": "https://urgent.news/2026/08/11/ex-legend-chief-ying-huang-becomes-ceo-of-k2-eyes-250m-series-a",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-11T12:00:44.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ex-legend-chief-ying-huang-becomes-ceo-of-k2-eyes-250m-series-a/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Ying Huang has spent the past seven years building up one of the leading cancer cell therapy players. Now, just weeks after announcing his departure as Legend Biotech's CEO, Huang is stepping ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}